NEW YORK, Oct. 23, 2025 (GLOBE NEWSWIRE) -- Progyny, Inc. (Nasdaq: PGNY), a global leader in women’s health and family building solutions, will report its financial results for the quarterly period ended September 30, 2025 after the close of the market on Thursday, November 6, 2025. The company will host a conference call at 4:45 P.M. Eastern Time (1:45 P.M. Pacific Time) and issue a press release regarding its financial results prior to the start of the call. Interested participants in the United States ma ...

Core Insights - Progyny, Inc. has appointed Elizabeth Bierbower to its Board of Directors, enhancing its leadership team with her extensive healthcare experience [1][2] - Bierbower has over 30 years of experience in the healthcare industry, having held significant roles in major health plans and provider services [2][3] - The company aims to expand its women's health and family building solutions, focusing on delivering value to members, clients, and shareholders [2][4] Company Overview - Progyny is recognized as a global leader in women's health and family building solutions, serving leading employers and health plans [5][7] - The company provides comprehensive benefits solutions that include concierge support, education, and access to a network of specialists, driving optimal clinical outcomes and reducing healthcare costs [6][5] - Progyny has received multiple accolades for its growth and influence, including being named a TIME100 Most Influential Company and a CNBC Disruptor 50 [7] Leadership and Strategy - Elizabeth Bierbower's leadership experience includes roles at Friday Health Plans and Humana, where she held various senior positions [2][3] - Her appointment is expected to support Progyny's strategy to innovate and expand its product offerings in women's health [2][4] - Bierbower expressed enthusiasm about joining Progyny at a pivotal time for the company's growth and commitment to high-quality care [4]